HEDIS Perinatal Depression Screening for Pennsylvania Health Plans: PPC, PND-E, PDS-E, and How to Close the Gaps

HEDIS perinatal depression screening (PND-E, PDS-E) and PPC postpartum visit rates still leave large gaps for PA Medicaid and commercial plans. This guide covers measure specs, 2023 rates, LOINC/ECDS pitfalls, and how closed-loop between-visit care closes gaps.

#TLDR

• PPC (Prenatal and Postpartum Care) tracks first-trimester prenatal care and a postpartum visit 7-84 days after delivery. It is a core HEDIS maternity measure for health plans. (NCQA – PPC)

• PND-E and PDS-E are HEDIS ECDS measures for prenatal and postpartum depression screening with a standardized instrument, plus follow-up within 30 days after a positive screen. (NCQA – PDS-E; Policy Center for Maternal Mental Health)

• National MY2023 averages remain low: Medicaid prenatal screening 13.2%, postpartum 8.7%; commercial 5.1% and 4.4%. Pennsylvania Medicaid led the U.S. on both prenatal (24.6%) and postpartum (24.1%) depression screening, yet that still means most deliveries go uncaptured in the measure. (Policy Center analysis of Quality Compass MY2023)

• ACOG recommends standardized screening for depression and anxiety at the initial prenatal visit, later in pregnancy, and postpartum, with systems for diagnosis, treatment, and follow-up. (ACOG Clinical Practice Guideline No. 4; PubMed)

• For PA plans and MCOs: the bottleneck is rarely “whether anyone cares.” It is documented, codeable screens + same-window follow-up + postpartum visit completion between sparse OB encounters. Phia is a licensed PA perinatal medical group that runs continuous screening, same-day clinical response, and claims-visible encounters while the OB stays the medical home. Partner with Phia · PA Medicaid postpartum coverage

Who this is for

Quality, population health, and maternity program leaders at Pennsylvania Medicaid MCOs and commercial plans, plus OB leaders who own HEDIS denominators in practice. If you report PPC, PND-E, or PDS-E, or you are preparing for tighter state expectations on maternal mental health, this is the operating map.

Patient-facing symptom education lives elsewhere: postpartum depression symptoms, postpartum anxiety signs and screening, and the postpartum depression test guide.

The three HEDIS measures that shape perinatal quality

1. PPC: Prenatal and Postpartum Care

What NCQA measures. Among live births in the measurement window, PPC assesses:

(NCQA – Prenatal and Postpartum Care (PPC))

Why it matters for plans. NCQA frames PPC as whether routine outpatient prenatal and postpartum care happened, not emergency treatment. Inadequate prenatal contact reduces chances to find and manage risk. Comprehensive postpartum care addresses sleep loss, pain, feeding difficulty, mental health, and social strain. More than half of maternal deaths occur after birth. (NCQA – PPC)

ACOG’s optimizing postpartum care guidance calls for contact soon after birth and a comprehensive visit within 12 weeks; HEDIS PPC’s 7-84 day window is the measure expression of that continuum. (NCQA summary of ACOG guidance on PPC page)

PA plan reality check. A single scheduled postpartum visit is easy to miss after a chaotic discharge, transportation barriers, childcare, or a member who feels “fine enough” until she is not. Visit completion is a contact and logistics problem as much as a clinical one. Pennsylvania Medicaid’s 12-month postpartum coverage extends the benefit window for care, but HEDIS PPC still keys off that early postpartum visit window. (KFF postpartum coverage tracker; Phia: PA Medicaid postpartum coverage)

2. PND-E: Prenatal Depression Screening and Follow-Up

What it is. An ECDS (Electronic Clinical Data Systems) HEDIS measure. Two rates:

1. Depression screening: Deliveries with a documented result from an age-appropriate standardized instrument during pregnancy (pregnancy start through delivery date).

2. Follow-up on positive screen: Among positives, follow-up care on or up to 30 days after the first positive screen (31 total days), via defined visit types, behavioral health encounters, case management with assessment, certain counseling codes, antidepressant dispense, or same-day full-length negative screen after a brief positive.

(Policy Center – measure specifications summary; NCQA HEDIS MY measure lists include PND-E)

3. PDS-E: Postpartum Depression Screening and Follow-Up

What NCQA states. Percentage of deliveries in which persons were screened for clinical depression in the postpartum period, and if positive, received follow-up.

• Depression Screening: Standardized instrument during the postpartum period.

• Follow-Up on Positive Screen: Follow-up within 30 days of a positive finding.

(NCQA – Postpartum Depression Screening and Follow-up (PDS-E))

Timing detail plans miss. Policy Center’s specification summary places the PDS-E screening window at 7-84 days after delivery for the documented standardized result, aligned with the postpartum visit window many quality teams already watch for PPC. (Policy Center)

Clinical stakes NCQA cites. Perinatal depression rates among women range roughly 12%–15%, with postpartum depression alone estimated as high as 20% in some U.S. regions. Untreated depression in pregnancy raises risk of severe postpartum depression, suicidality, and preterm or low-birthweight delivery. Screening and treatment can be cost-saving; one cited analysis estimated about $1,000 per woman screened/treated versus about $10,200 in savings per remission. Measures rest on USPSTF and ACOG screening recommendations, with AAP recommending maternal screening at infant well visits. (NCQA – PDS-E)

Why reported screening rates stay low (even when clinics “screen”)

National and Pennsylvania benchmarks (MY2023)

From the Policy Center for Maternal Mental Health analysis of NCQA Quality Compass MY2022-2023:

(Policy Center – Latest HEDIS Maternal Mental Health Screening Rates, Nov 21, 2025)

Follow-up after a positive screen (national 2023 averages): prenatal follow-up ~50.4% Medicaid / 58.5% commercial; postpartum follow-up ~62.1% Medicaid / 66.3% commercial. Screening is only half the measure. (Policy Center)

Reporting is widespread but still voluntary for accreditation. In 2023, about 73% of Medicaid HEDIS reporters and 92-93% of commercial reporters submitted PND-E/PDS-E even though the measures were voluntary for NCQA accreditation and flagged voluntary in the CMS Adult Core Set context the Policy Center describes. (Policy Center)

Pennsylvania is already a leader, not a finished story. PA Medicaid’s ~24% screening rates top the state table and still leave roughly three in four deliveries outside the numerator as reported. Commercial PA rates sit near 8-11%. Leading is not the same as closing the gap. (Policy Center)

Geisinger Health Plan appears in top-insurer tables for both Medicaid and commercial screening in that analysis, a signal that integrated systems with stronger data capture outperform the market average. (Policy Center)

Two structural reasons rates under-count true clinical activity

The Policy Center flags two drivers quality teams should treat as design constraints:

1. LOINC / ECDS requirements. PND-E and PDS-E need electronic documentation of the specific standardized instrument (LOINC-coded). Paper screens, free-text “mood OK,” or tools without the right observation codes often never enter the numerator, even when a clinician asked the questions.

2. Voluntary reporting incentives. When measures are voluntary, some plans invest less in complete clinical data pipelines, which can artificially suppress rates relative to real-world screening.

(Policy Center)

State Medicaid agencies can still require MCO reporting. The Policy Center notes PA among agencies that require PDS-E or PND-E reporting from Medicaid MCOs, alongside CA, IN, MI, NH, NV, WA, and WI, and notes PA among states that also provide separate Medicaid reimbursement for MMH screening. (Policy Center)

What “good” looks like clinically (ACOG), vs what HEDIS can see

ACOG’s Clinical Practice Guideline No. 4 addresses screening and diagnosis of mental health conditions in pregnancy and postpartum, including depression and anxiety at key visits. (ACOG CPG No. 4; PubMed abstract)

Plan implication: A program that only optimizes the depression HEDIS codes still leaves anxiety-dominant members under-served clinically. Pair measure ops with anxiety-capable pathways (for example EPDS plus GAD-7 where appropriate). See Phia’s clinical explainers on postpartum anxiety and PPD symptoms.

Where PA plan and MCO programs break

1. The between-visit desert

OB schedules concentrate risk detection into short visits. Mood can crash on a Tuesday night weeks after discharge. Without a between-visit owner, elevated scores wait for the next appointment that may never happen inside the 7-84 day window.

2. Screen without closed-loop follow-up

A positive EPDS that sits in a portal message queue fails the 30-day follow-up rate even if the screen itself was perfect.

3. Data that never becomes ECDS

Staff complete a paper EPDS; no LOINC observation lands in the extract. Numerators stay flat while clinicians insist “we screen everyone.”

4. Postpartum visit no-shows

PPC postpartum depends on a completed visit in window. Transportation, NICU chaos, returning to work, and distrust of “another appointment” all suppress the rate. Reminder robocalls alone rarely fix it.

5. Fragmented BH access

A referral to a 6-week waitlist is not follow-up inside 30 days. Plans need rapid clinical capacity (therapy, med management, care management encounters that meet value sets), not only directories.

6. SDOH as a silent denominator problem

Housing, food, and intimate partner safety drive missed visits and untreated depression. Screening without resource linkage burns trust. Phia’s SDOH matching work is one example of closing that loop in PA. (SDOH resource finder; Phia SDOH announcement)

Operating model that moves PPC + PND-E + PDS-E together

Treat the three measures as one perinatal quality system, not three siloed QI projects.

A. Own the calendar windows

B. Make screening electronic-first

• Prefer in-app or EHR-embedded EPDS/PHQ tools that emit the right codes.

• Avoid “screened in chat, never charted.”

• Train on which instruments your HEDIS vendor maps.

C. Assign follow-up SLAs in hours, not weeks

Positive screens should page a named clinical owner the same day. 30 calendar days is the HEDIS outer bound, not the clinical goal.

D. Chase postpartum visits as care, not compliance

Text and call as a care team, offer flexible virtual + in-person options where benefits allow, and fix transportation before the third no-show.

E. Keep the OB as medical home

Summaries back to the referring OB protect continuity and reduce duplicate work. Plans should require closed-loop documentation from any maternity vendor or medical group partner.

F. Verify in claims and clinical data

Platform PDFs do not equal HEDIS. Prefer partners who generate billable, documented encounters your analytics can see.

How Phia fits for Pennsylvania plans and providers

Phia Health is a licensed Pennsylvania perinatal medical group (not a wellness subscription). The model is built for the exact failure points above:

For health plans: population referral of hard-to-reach maternity members, quality measure alignment on postpartum visits, screening, and behavioral follow-up, in-network delivery. Details: Partners – payors and providers.

For OB practices: fax, EHR, or secure-link referral without a new IT project; Phia absorbs between-visit follow-up. Free tools anytime: perinatal screening scales and SDOH resource finder.

UnitedHealthcare Community Plan: dedicated coverage path at UnitedHealthcare.

Request a partnership conversation: app.phiahealth.com/request-info.

90-day checklist for a PA plan maternity quality sprint

Days 1-30 – Baseline

• Pull PPC prenatal/postpartum rates and PND-E/PDS-E screening + follow-up by product and region.

• Map which providers submit LOINC-capable depression screens vs paper.

• Identify members delivering in the next 90 days without a scheduled postpartum visit.

Days 31-60 – Close the loop

• Stand up same-day escalation for positive perinatal screens (internal BH or contracted medical group).

• Embed standardized instruments in the highest-volume OB and midwifery groups.

• Launch structured postpartum visit outreach at day 3-5 and day 14 if unscheduled.

Days 61-90 – Prove it

• Audit 50 charts: screen present, coded, follow-up inside 30 days.

• Compare no-show rates before/after outreach redesign.

• Lock 2026 vendor and MCO reporting requirements so voluntary ECDS measures are operationally mandatory inside your plan.

FAQ for plan quality teams

Does a positive screen without treatment still help the measure?

Screening numerators count documented standardized results. The follow-up rate only applies after a positive. A positive with no qualifying follow-up in 30 days hurts the follow-up indicator. (NCQA PDS-E; Policy Center specs)

Is anxiety in HEDIS the same way depression is?

ACOG pushes depression and anxiety screening clinically. PND-E/PDS-E as described here center on depression screening instruments and follow-up. Build anxiety pathways for outcomes even when the HEDIS code set is depression-first. (ACOG CPG No. 4)

Why is Pennsylvania “high” and still a priority?

PA Medicaid’s ~24% screening rates lead state tables and remain far from universal capture. Commercial rates lag further. Leadership without a closed-loop partner still leaves most members outside the numerator. (Policy Center)

How does 12-month Medicaid postpartum coverage interact with HEDIS?

Extended coverage improves access for late-onset depression and ongoing treatment across the year. PPC and PDS-E still emphasize early postpartum windows (notably 7-84 days). Use the full year for treatment continuity; do not wait until month six to complete the measure windows. (KFF; Phia PA Medicaid guide)

Conclusion

HEDIS perinatal performance for Pennsylvania plans is a systems problem: coded screens, 30-day follow-up, and postpartum visits inside tight windows, all while members live most of pregnancy and the fourth trimester between OB appointments. National PND-E/PDS-E averages remain in the single digits to low teens; PA Medicaid leads and still has a wide gap to close. (Policy Center; NCQA PPC; NCQA PDS-E)

If you own maternity quality for a PA plan or MCO, pair measure literacy with a between-visit clinical partner that documents like a medical group. Talk to Phia about partnership or review the partner model.

Educational overview for quality and clinical leaders. Confirm current HEDIS specs with your certified measure vendor and NCQA materials for the active measurement year. Not legal, coding, or medical advice.